
© 2026 börsennews.de
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 36,890 | 37,020 | 13:02 | |
| 37,250 | 37,405 | 05.06. |

| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15:27 | Novo's Wegovy Pill Isn't Just Beating Expectations -- It's Obliterating Them. Is the Beaten-Down Stock a Buy Now? | ||
| 15:12 | Novo Nordisk: People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more likely to achieve greater than 5% weight loss than those who were switched to tirzepatide, in real-world data | Adults with type 2 diabetes on semaglutide 1 mg whose dose was increased to 2 mg were as likely to reach an HbA1c level 1 This retrospective claims analysis, across >64,000 US adults, offered... ► Artikel lesen | |
| 13:30 | DRINGEND: Novo nordisk: Warum erfahrene Anleger zum Wochenstart die Reißleine ziehen - Was Monday-Trader jetzt wissen sollten | ||
| 09:30 | SCHOCKMELDUNG bei Novo nordisk: Droht jetzt der nächste große Absturz? - Was sich am Wochenende verändert hat! | ||
| Fr | Eilmeldung am Abend: NOVO NORDISK A/S zeigt Nervenstärke! |